Live Breaking News & Updates on Shinichiro Nishishita|Page 2

Stay updated with breaking news from Shinichiro nishishita. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nxera Pharma joins the World Orphan Drug Alliance

Nxera Pharma joins the World Orphan Drug Alliance
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Soult Ukpyolsi , South Korea , City Of , Sosei Heptares , Patrick Jordan , Frazer Hall , Kentaro Tahara , Erica Hollingsworth , Shinichiro Nishishita , Chris Cargill , Tina Vojnovic , Nxerapharma Youtube , Maya Bennison , Nxera Pharma , Sosei Group Or Heptares , Ltd Nxera , Head Of Corporate Communications , Tokyo Stock Exchange , Nxera Pharma Co , Medistrava Consulting For International Media , World Orphan Drug Alliance , Nxera Pharma Group , World Orphan Drug , Sosei Group , Named Patient Programs ,

Nxera Pharma Appoints Experienced Senior Strategy Consultant Patrick Branch as Head of Business Development for Japan and APAC

Tokyo, Japan and Cambridge, UK, 3 April 2024 - Nxera Pharma (“Nxera” or “the Company”; TSE: 4565) – formerly known as Sosei Group or Sosei Heptares – today announces the appointment of Japan pharmaceutical sector expert, Mr. Patrick Branch, as Head of Business Development for Japan and the APAC region. Mr. Branch will join Nxera’s global Business Development team that is led by Dr. Marcus Messenger. He will be based in Nxera’s Tokyo office and will oversee Japan and regional disease area strateg ....

United Kingdom , Soult Ukpyolsi , South Korea , United States , Columbia University , New York , City Of , Chris Cargill , Frazer Hall , Maya Bennison , Kentaro Tahara , Erica Hollingsworth , Nxera Pharma , Shinichiro Nishishita , Nxerapharma Youtube , Sosei Heptares , Patrick Branch , Masters Of Public Health , University Of Nottingham , University Of London , Head Of Business Development For Japan , Mailman School Of Public Health New York , Medistrava Consulting For International Media , Sosei Group Or Heptares , Tokyo Stock Exchange , Business Development ,

Sosei Heptares Confirms Re-election of its Board and Executive Management Team and the Approval of Change of Company Name to Nxera Pharma

Sosei Heptares Confirms Re-election of its Board and Executive Management Team and the Approval of Change of Company Name to Nxera Pharma
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Soult Ukpyolsi , South Korea , City Of , Kazuhiko Yoshizumi , Frazer Hall , Candelle Chong , Kieran Johnson , Kuniaki Kaga , David Roblin , Nxera Pharma , Maya Bennison , Keiko Tomita , Tomohiro Tohyama , Toshihiro Maeda , Matt Barnes , Sosei Heptares , Shinichi Tamura , Erica Hollingsworth , Noriaki Nagai , Shinichiro Nishishita , Rolf Soderstrom , Miwa Seki , Satoshi Tanaka , Kentaro Tahara , Hironoshin Nomura ,

Sosei Heptares Confirms Re-election of its Board and

Sosei Heptares Confirms Re-election of its Board and
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , Soult Ukpyolsi , South Korea , Chris Cargill , Tomohiro Tohyama , Shinichi Tamura , Erica Hollingsworth , Maya Bennison , Satoshi Tanaka , Miwa Seki , Toshihiro Maeda , Nxera Pharma , Kazuhiko Yoshizumi , Rolf Soderstrom , Keiko Tomita , Frazer Hall , Kieran Johnson , Hironoshin Nomura , Noriaki Nagai , Kuniaki Kaga , Sosei Heptares , Candelle Chong , Shinichiro Nishishita , David Roblin , Kentaro Tahara ,

Boehringer Ingelheim and Sosei Heptares join forces to develop first-in-class treatments targeting all symptoms of schizophrenia

Single-target agreement focused on development of novel, small molecule agonists of GPR52 discovered by Sosei Heptares with the potential to simultaneously address positive, negative and cognitive symptoms of schizophreniaSosei Heptares will receive EUR 25 million upfront from Boehringer Ingelheim and is eligible for an option exercise payment of EUR 60 million and further milestone payments totaling up to EUR 670 million plus tiered royalties Ingelheim, Germany, Tokyo, Japan and Cambridge, UK, ....

United Kingdom , City Of , Soult Ukpyolsi , South Korea , New York , United States , Rheinland Pfalz , Sosei Heptares , Erica Hollingsworth , Kentaro Tahara , Frazer Hall , Sosei Heptare , Linda Ruckel , Reinhard Malin , Shinichiro Nishishita , Maya Bennison , Matt Barnes , Hugh Marston , Group Of Schizophrenias , Schizophrenia Research , Discovery Research At Boehringer Ingelheim , Sosei Group , Medistrava Consulting For International Media , Sosei Group Corporation Heptares , Sosei Group Corporation , Boehringer Ingelheim ,